Effect of Citrus aurantium var amara on weight change in mice > Volume 08 - 2008

본문 바로가기

사이트 내 전체검색


 » New Articles(2011~Present)
 » Articles (2001~2010)
      ∙ Volume 10 - 2010
      ∙ Volume 09 - 2009
      ∙ Volume 08 - 2008
      ∙ Volume 07 - 2007
      ∙ Volume 06 - 2006
      ∙ Volume 05 - 2005
      ∙ Volume 04 - 2004
      ∙ Volume 03 - 2003
      ∙ Volume 02 - 2002
      ∙ Volume 01 - 2001
 

Oriental Pharmacy and Experimental Medicine
Volume 08 - 2008
Date: August 22, 2006

Journal: Pages 222-227

September 2008 | Effect of Citrus aurantium var amara on weight change in mice…

Satyajit Dey Sarker1,*, Bohlol Habibi2, Tohid Sharifi2, Solmaz Asnaashari3, Lutfun Nahar1 andAbbas Delazar4

첨부파일

Summary

​Citrus aurantium var. amara L., commonly known as ‘bitter orange’ or ‘sour orange’, of the familyRutaceae, has traditionally been used in the treatment of various ailments, and it possessesdifferent types of pharmacological properties. As a part of our on-going studies on the plantsfrom the Iranian flora, the extract of C. aurantium var. amara has been studied for its weight lossproperties using the mice model. While the Sep-Pak fraction, 20% methanol (MeOH) in water, ofthe hydro-methanolic extract of the peels of C. aurantium var. amara fruits, when injectedintraperitoneal (i.p.) at a dose of 10 mg/kg, significantly decreased the level of weight gain of themice in comparison with control the group (P < 0.01), the Sep-Pak fraction 80% MeOH in waterdecreased the initial weight of mice by 0.44% in six weeks. The administration of the total extract(10 and 20 mg/kg, i.p.), and the Sep-Pak fractions, 40% and 60% MeOH in water (10 mg/kg, i.p.)did not show any significant change of weight of the test mice. Of the two active fractions, the80% MeOH in water fraction did not show any noticeable adverse effects on mice, and wastherefore analysed by reversed-phase preparative high performance liquid chromatographyresulting in the isolation and identification of four major components, two coumarins, meranzinhydrate (1) and bergamottin (2), and two flavonoids, xanthomicrol 5,4’-di-methyl ether(tangeritin, 3) and hymenoxin 5,7-di-methyl ether (nobiletin, 4).


This website Copyright (c) 2014 Institute of Korean Medicine Kyung Hee University All rights reserved.
Top View
Mobile View